ProCE Banner Activity

Estudios clave sobre el VIH que influyen en mi actividad profesional después de la CROI 2023

Slideset

Descargue las diapositivas para examinar los resúmenes de los principales estudios sobre el VIH de la CROI 2023, incluso los resultados de los estudios sobre estrategias de prevención, tratamientos de acción prolongada, eventos adversos de la terapia antirretroviral, tratamientos de segunda línea y coinfección.

Released: March 23, 2023

Share

Faculty

Orkin Chloe

Orkin Chloe, BA Innere Medizin und Chirurgie, Fellow des Royal College of Medicine

Professorin für HIV
Queen Mary University of London  
Fachärztin
Leiterin der Abteilung für HIV-Forschung
Barts Health NHS Trust
The Royal London Hospital
London, Vereinigtes Königreich

Eric S. Daar

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Joseph J. Eron, Jr.

Joseph J. Eron, Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Monica Gandhi

Monica Gandhi, MD, MPH

Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco 
San Francisco, California

Princy N Kumar

Princy N Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Babafemi Taiwo

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare